Last edition
News about "pTau217 blood test"
Roche's Elecsys pTau217 Gets US FDA Clearance for Alzheimer's Assessment
Roche’s Elecsys pTau217 receives US Food and Drug Administration (FDA) clearance as a blood test for Alzheimer’s amyloid pathology assessment across primary and specialty care settings.
PTau217 Blood Test | 25/08/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members